PAMELA CRAMER: Open Payments
NPI 1487129243 · BELLEVUE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 43 payments from 22 companies in 2025. Trend: 2023 $876 · 2024 $707 · 2025 $905
Food & beverage: $730Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $182 |
| ABBVIE INC. | 10 | $146 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| Novo Nordisk Inc | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $31 |
Products named: PROLIA, VOQUEZNA, LINZESS, REXULTI, QULIPTA, Qelbree, ZENPEP, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
